Clinical Trials Browser

Phase 1 × pazopanib × Genitourinary × Clear all

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

Clinical Trials

IVY

Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)

Exploratory Study of Radium-223 and VEGF-Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma and Bone Mets

Safety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC; KEYNOTE-018)

Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer

Expanded Phase I Pazopanib and Everolimus in Advanced Solid Tumors and Previously Treated Advanced Urothelial Cancer

Study To Assess Long Term Safety Of Pazopanib

Pazopanib, Docetaxel, Prednisone Prostate

Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients

A Two-way Crossover Study Of The Effect Of Food On The Pharmacokinetics Of Pazopanib In Cancer Patients

Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034

VEG111485: A QTc Study of Pazopanib

A Study To Test The Effect Of GW786034 (Pazopanib) On P450 Enzymes

Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors

An Open-Label Pharmacodynamic Study of Bevacivumab and Pazopanib in Renal Cell Carcinoma

A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors